United States · Health Care · USD (Millions) · Annual
Key financials
USD|Millions
ROE
35.03%
2025 (actual)
ROA
14.13%
2025 (actual)
Gross Margin
67.88%
2025 (actual)
Net Margin
28.46%
2025 (actual)
Total Assets
$199,210.00M
2025 (actual)
Net Income
$26,804.00M
2025 (actual)
Valuation
$495,558.54M
2026 (forecast)
Stock Price
$205.86
Historical & projected performance
USD|Millions
Reported figures and Equlion model projections for the next 5 years.
ROE
-26.5 pt
Company
Sector average
ROA
-9.7 pt
Company
Gross Margin
-14.8 pt
Company
Sector average
Net Margin
-19.5 pt
Company
Total Assets
+74.8%
Company
Sector average (own scale)
Net Income
-44.3%
Company
Valuation
+18.7%
Company
Sector average
Stock Price
+18.7%
Company
Sector average (own scale)
Amounts in USD (millions); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2026. Projections are model estimates, not investment advice.
Want the full financial forecast report for JOHNSON & JOHNSON? It covers the balance sheet, income statement, cash flow and Equlion model projections.